Skip Navigation

European Heart Journal 2000 21(12):981-991; doi:10.1053/euhj.2000.1946
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (29)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Baer, F.M
Right arrow Articles by Erdmann, E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baer, F.M
Right arrow Articles by Erdmann, E
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Head to head comparison of dobutamine–transoesophageal echocardiography and dobutamine–magnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery disease

F.M Baera,f1, P Theissenb, J Crnaca, M Schmidtb, H.J Deutscha, U Sechtema, H Schichab and E Erdmanna

a Klinik III für Innere Medizin, der Universität zu Köln, Köln, Germany
b Klinik und Poliklinik für Nuklearmedizin, der Universität zu Köln, Köln, Germany

accepted October 1, 1999

Abstract

Aims A substantial number of patients with dysfunctional but potentially viable myocardium cannot be accurately evaluated by transthoracic echocardiography due to a poor acoustic window. This study compares the diagnostic value of alternative functional imaging techniques, such as dobutamine–transoesophageal echocardiography (dobutamine–TEE) and dobutamine magnetic resonance imaging (dobutamine–MRI) for the detection of viable myocardium and the prediction of left ventricular functional recovery in patients with chronic coronary artery disease following successful revascularization procedures.

Methods and Results Rest and low-dose (5, 10µg dobutamine.min–1.kg–1) multiplane dobutamine–TEE and ultrafast cine–MRI studies were performed in 103 patients. Contractile recovery of an infarct region was predicted if a dobutamine contraction reserve could be assessed visually by TEE or MRI in ≥50% of infarct-related a- or dyskinetic segments. Revascularization of the infarct-related vessel was successful in 88 patients, and 4·9±0·7 months later 52 patients still had an angiographically controlled open target vessel. These patients underwent another rest MRI study to assess left ventricular functional recovery. A dobutamine contraction reserve was observed in 27/52 (52%) patients by TEE and in 26/52 (50%) patients by MRI. Functional improvement of the infarct region was diagnosed in 28/52 (54%) patients. The positive and negative predictive accuracy of dobutamine–TEE and dobutamine–MRI for the prediction of left ventricular functional recovery was not significantly different (85% vs 92%, ns and 80% vs 85%, ns). Diagnosis of a predominantly viable infarct region by TEE and MRI predicted a significant increase in left ventricular ejection fraction (TEE: 12±8% vs 2±7%P<0·001, MRI: 13±7% vs 2±7%, P<0·001) compared to infarct regions graded as scar.

Conclusion A qualitative visual analysis of TEE and MRI viability studies is highly accurate for the prediction of left ventricular functional recovery in patients with dysfunctional myocardium and proved to be a clinically valuable alternative if transthoracic dobutamine–echocardiography is unsuitable. To date, TEE is cardiologists' preferred choice for the assessment of myocardial viability but MRI may become significantly more attractive with increasing local availability and experience.

Key Words: Myocardial infarction, dobutamine, transoesophageal echocardiography, magnetic resonance imaging, viability

f1 Correspondence: Frank Michael Baer, MD, Klinik III für Innere Medizin, Universität zu Köln, Joseph-Stelzmann-Str. 9, D-50924 Köln, Germany.

References

  1. Gould KL. Myocardial viability. What does it mean and how to measure it. Circulation. 1991;83:333–335[Free Full Text]
  2. Braunwald E, Rutherford J. Reversible ischemic left ventricular dysfunction: evidence of the ‘hibernating myocardium’. J Am Coll Cardiol. 1986;8:1467–1470[Web of Science][Medline]
  3. Pierard LA, DeLandsheere CM, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with PET. J Am Coll Cardiol. 1990;15:1021–1031[Abstract]
  4. Smart SC, Sawada S, Ryan T. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation. 1993;88:405–415[Abstract/Free Full Text]
  5. Cigarroa CG, deFilippi CR, Brickner ME, Alvarez LG, Wait MA, Grayburn PA. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation. 1993;88:430–436[Abstract/Free Full Text]
  6. LaCanna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol. 1994;23:617–627[Abstract]
  7. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol. 1997;30:1451–1460[Abstract]
  8. Baer FM, Voth E, Deutsch H, Schneider CA, Schicha H, Sechtem U. Assessment of viable myocardium by dobutamine-transesophageal-echocardiography (TEE) and comparison with FDG-PET. J Am Coll Cardiol. 1994;24:343–353[Abstract]
  9. Baer FM, Voth E, Deutsch H, Schneider CA. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18-fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. J Am Coll Cardiol. 1996;28:60–69[Abstract]
  10. Baer FM, Voth E, Schneider CA, Theissen P, Schicha H, Sechtem U. Dobutamine-gradient echo MRI: a functional and morphologic approach to the detection of residual myocardial viability. Circulation. 1995;91:1006–1015[Abstract/Free Full Text]
  11. Dendale PAC, Franken RP, Waldmann GJ. Low-dosage dobutamine magnetic resonance imaging as an alternative to echocardiography in the detection of viable myocardium after acute infarction. Am Heart J. 1995;130:134–140[CrossRef][Web of Science][Medline]
  12. Baer FM, Theissen P, Schneider CA. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol. 1998;31:1040–1048[Abstract/Free Full Text]
  13. Lucignani G, Paolini G, Landoni C. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease. Eur J Nucl Med. 1992;19:874–881[CrossRef][Web of Science][Medline]
  14. Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW. Quantitative planar rest-redistribution 201-thallium imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation. 1993;87:1630–1641[Abstract/Free Full Text]
  15. Brunken R, Tillisch J, Schwaiger M. Regional perfusion, glucose metabolism and wall motion in patients with chronic electrocardiographic Q-wave infarctions: evidence of persistence of viable tissue in some infarct regions by positron emission tomography. Circulation. 1986;73:951–963[Abstract/Free Full Text]
  16. Tamaki N, Yonekura Y, Yamashita K. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol. 1989;64:860–865[CrossRef][Web of Science][Medline]
  17. Gould KI, Yoshida K, Hess MJ, Haynie M, Mullani N, Smalling RW. Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity for the potassium analogue rubidium 82 for assessing infarct size in man by PET. J Nucl Med. 1991;32:1–9[Abstract/Free Full Text]
  18. Perrone-Filardi P, Pace L, Prastaro M. Dobutamine-echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation. 1995;91:2556–2565[Abstract/Free Full Text]
  19. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation. Circulation. 1995;91:663–670[Abstract/Free Full Text]
  20. Bax JJ, Cornel JH, Visser FC. Prediction of recovery of myocardial dysfunction following revascularization: comparison of F18-fluorodeoxyglucose/thallium-201 single photon computed emission tomography, thallium-201 stress-reinjection single photon emission tomography and dobutamine echocardiography. J Am Coll Cardiol. 1996;28:558–564[Abstract]
  21. Vanoverschelde J-Lj, D'Hondt AM, Marwick T. Head-to-head comparison of exercise-redistribution-reinjection thallium single photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol. 1996;28:432–444[Abstract]
  22. Gunning MG, Anagnostopoulos C, Knight CJ. Comparison of 201-TL, 99mTc-Tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. Circulation. 1998;98:1869–1874[Abstract/Free Full Text]
  23. Baer FM, Voth E, LaRosee K. Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability. Am J Cardiol. 1996;78:414–419
  24. Lieberman AN, Weiss JL, Jugdutt BI. Two dimensional echocardiography and infarct size: relationship of regional wall motion thickening to the extent of myocardial infarction in the dog. Circulation. 1981;63:739–746[Free Full Text]
  25. Bodenheimer MM, Banka VS, Hermann GA, Trout RG, Pasdar H, Helfant R. Reversible asynergy: histopathologic and electrocardiographic correlations in patients with coronary artery disease. Circulation. 1979;53:792–796
  26. Bax JJ, Cornel JH, Visser VC. Prediction of improvement of contractile function in patients with ischemic ventricular dysfunction after revascularization by fluorine-18 fluorodeoxyglucose single-photon emission computed tomography. J Am Cardiol. 1997;30:377–383
  27. Yang PC, Kerr AB, Liu AC. New real-time interactive cardiac magnetic resonance imaging system complements echocardiography. J Am Coll Cardiol. 1998;32:2049–2056[Abstract/Free Full Text]
  28. Nagel E, Lehmkuhl HB, Bocksch W. Noninvasive diagnosis of ischemia induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation. 1999;99:763–770[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CirculationHome page
P. G. Camici, S. K. Prasad, and O. E. Rimoldi
Stunning, Hibernation, and Assessment of Myocardial Viability
Circulation, January 1, 2008; 117(1): 103 - 114.
[Full Text] [PDF]


Home page
HeartHome page
T A M Kaandorp, H J Lamb, E E van der Wall, A de Roos, and J J Bax
Cardiovascular MR to access myocardial viability in chronic ischaemic LV dysfunction
Heart, October 1, 2005; 91(10): 1359 - 1365.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. P. Cupps, B. J. Pomerantz, M. D. Krock, J. Villard, J. Rogers, N. Moazami, and M. K. Pasque
Principal Strain Orientation in the Normal Human Left Ventricle
Ann. Thorac. Surg., April 1, 2005; 79(4): 1338 - 1343.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S.R. Underwood, J. J Bax, J. v. Dahl, M. Y Henein, A. C van Rossum, E. R Schwarz, J.-L. Vanoverschelde, E. E.v. d. Wall, and W. Wijns
Imaging techniques for the assessment of myocardial hibernation: Report of a Study Group of the European Society of Cardiology
Eur. Heart J., May 2, 2004; 25(10): 815 - 836.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Shan, G. Constantine, M. Sivananthan, and S. D. Flamm
Role of Cardiac Magnetic Resonance Imaging in the Assessment of Myocardial Viability
Circulation, March 23, 2004; 109(11): 1328 - 1334.
[Full Text] [PDF]


Home page
Eur J Heart FailHome page
J.G.F. Cleland, N. Freemantle, S.G. Ball, R.S. Bonser, P. Camici, S. Chattopadhyay, D. Dutka, J. Eastaugh, J. Hampton, S. Large, et al.
The heart failure revascularisation trial (HEART): rationale, design and methodology
Eur J Heart Fail, June 1, 2003; 5(3): 295 - 303.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
C. R. Weiss, A. H. Aletras, J. F. London, J. L. Taylor, F. H. Epstein, R. Wassmuth, R. S. Balaban, and A. E. Arai
Stunned, Infarcted, and Normal Myocardium in Dogs: Simultaneous Differentiation by Using Gadolinium-enhanced Cine MR Imaging with Magnetization Transfer Contrast
Radiology, March 1, 2003; 226(3): 723 - 730.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J.J. Bax and E.E. Van der Wall
Assessment of myocardial viability: guide to prognosis and clinical management
Eur. Heart J., June 2, 2000; 21(12): 961 - 963.
[PDF]


Home page
RadiologyHome page
J. N. Oshinski, H.-C. Han, D. N. Ku, and R. I. Pettigrew
Quantitative Prediction of Improvement in Cardiac Function after Revascularization with MR Imaging and Modeling: Initial Results
Radiology, November 1, 2001; 221(2): 515 - 522.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (29)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Baer, F.M
Right arrow Articles by Erdmann, E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baer, F.M
Right arrow Articles by Erdmann, E
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?